phenyl acetate has been researched along with Dyslipidemias in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (15.38) | 29.6817 |
2010's | 10 (76.92) | 24.3611 |
2020's | 1 (7.69) | 2.80 |
Authors | Studies |
---|---|
Zucchi, R | 1 |
Chen, H; Olatunji, OJ; Zhou, Y | 1 |
Aiyer, A; Asp, P; Barahman, M; Beck, AP; Guha, C; Harris, HY; Kabarriti, R; Kinkhabwala, M; Roy-Chowdhury, J; Roy-Chowdhury, N; Scanlan, TS; Zhang, W | 1 |
Abdallah, M; Abi Rafeh, N; Bhat, T; El-Sayegh, S; Kalantar-Zadeh, K; Khoueiry, G; Lafferty, J; Raza, M; Saiful, F | 1 |
Chew, GT; Sahebkar, A; Watts, GF | 1 |
Lammel Lindemann, J; Webb, P | 1 |
Gotto, AM; Pownall, HJ | 1 |
Eller, P; Patsch, JR; Ritsch, A; Tancevski, I | 1 |
Cioffi, F; Goglia, F; Lanni, A | 1 |
Demetz, E; Eller, P; Tancevski, I | 1 |
Bateman, K; Chan, CC; Huang, Z; Landry, F; Leclair, G; Li, CS; Oballa, R; Zhang, L | 1 |
Choi, YJ; Geaney, JC; Karpf, DB; Krauss, RM; Naim, S; Roberts, BK; Wang, X; Wojnoonski, K | 1 |
Berry, C; Grégoire, J; Ibrahim, R; L'Allier, PL; Lespérance, J; Levesque, S; Tardif, JC | 1 |
7 review(s) available for phenyl acetate and Dyslipidemias
Article | Year |
---|---|
Thyroid Hormone Analogues: An Update.
Topics: Acetates; Anilides; Animals; Central Nervous System Diseases; Clinical Trials as Topic; Diiodothyronines; Drug Design; Dyslipidemias; Humans; Liver Diseases; Male; Mice; Mutation; Non-alcoholic Fatty Liver Disease; Phenols; Pyridazines; Rats; Signal Transduction; Thyroid Hormone Receptors alpha; Thyroid Hormone Receptors beta; Thyroid Hormones; Thyronines; Triiodothyronine; Uracil | 2020 |
High-density lipoprotein in uremic patients: metabolism, impairment, and therapy.
Topics: Acetamides; Acetates; Acetyl-CoA C-Acetyltransferase; Anti-Inflammatory Agents; Anticholesteremic Agents; Antioxidants; Apolipoprotein A-I; Atherosclerosis; Cholesterol; Cholesterol Ester Transfer Proteins; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins, HDL; Niacin; PPAR alpha; Quinolines; Renal Insufficiency, Chronic; Sulfonamides; Sulfonic Acids; Uremia | 2014 |
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides | 2014 |
New Insights into the High-Density Lipoprotein Dilemma.
Topics: Acetates; Alcohols; Animals; Atherosclerosis; Cardiovascular Diseases; Dyslipidemias; Humans; Lipoproteins, HDL; Receptors, G-Protein-Coupled | 2016 |
The resurgence of thyromimetics as lipid-modifying agents.
Topics: Acetates; Anilides; Animals; Anticholesteremic Agents; Arteriosclerosis; Atherosclerosis; Biological Transport; Biomimetics; Cholesterol, LDL; Clinical Trials as Topic; Dyslipidemias; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipid Metabolism; Malonates; Molecular Structure; Organophosphonates; Phenols; Phenyl Ethers; Phenylacetates; Propionates; Pyridazines; Receptors, LDL; Thyroid Gland; Thyroid Hormones | 2009 |
Thyroid hormones, mitochondrial bioenergetics and lipid handling.
Topics: Acetates; Adiposity; Anilides; Animals; Atherosclerosis; Cardiovascular Diseases; Clinical Trials as Topic; Diiodothyronines; Dyslipidemias; Energy Metabolism; Fatty Liver; Humans; Lipid Metabolism; Mice; Mitochondria; Obesity; Phenols; Rats; Thyroid Hormones | 2010 |
Sobetirome: a selective thyromimetic for the treatment of dyslipidemia.
Topics: Acetates; Animals; Bile Acids and Salts; Biomarkers; Cholesterol; Dyslipidemias; Humans; Hypolipidemic Agents; Liver; Molecular Mimicry; Phenols; Receptors, LDL; Thyroid Hormones; Treatment Outcome; Triglycerides | 2011 |
1 trial(s) available for phenyl acetate and Dyslipidemias
Article | Year |
---|---|
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia.
Topics: Acetates; Analysis of Variance; Atherosclerosis; Atorvastatin; Biomarkers; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypolipidemic Agents; Lipoproteins; Male; Middle Aged; Obesity; Overweight; Particle Size; PPAR gamma; Pyrroles; Time Factors; Treatment Outcome; Triazoles | 2012 |
5 other study(ies) available for phenyl acetate and Dyslipidemias
Article | Year |
---|---|
Effect of the Polyphenol Rich Ethyl Acetate Fraction from the Leaves of Lycium chinenseMill. on Oxidative Stress, Dyslipidemia, and Diabetes Mellitus in Streptozotocin-Nicotinamide Induced Diabetic Rats.
Topics: Acetates; Animals; Blood Glucose; Body Weight; Diabetes Mellitus, Experimental; Dyslipidemias; Lycium; Male; Niacinamide; Oxidative Stress; Plant Leaves; Polyphenols; Rats; Rats, Sprague-Dawley; Streptozocin | 2017 |
Radiation-primed hepatocyte transplantation in murine monogeneic dyslipidemia normalizes cholesterol and prevents atherosclerosis.
Topics: Acetates; Animals; Apolipoproteins E; Atherosclerosis; Cholesterol; Disease Models, Animal; Dyslipidemias; Female; Hepatocytes; Hyperlipoproteinemia Type II; Male; Mice; Mice, Inbred C57BL; Phenols | 2019 |
Sobetirome: the past, present and questions about the future.
Topics: Acetates; Animals; Cardiovascular Diseases; Cholesterol; Clinical Trials as Topic; Dogs; Dyslipidemias; Humans; Liver; Phenols; Thyroid Hormone Receptors beta | 2016 |
Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors.
Topics: Acetates; Animals; Biological Assay; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Deuterium; Diabetes Mellitus; Dyslipidemias; Enzyme Inhibitors; Humans; Liver; Male; Mass Spectrometry; Molecular Targeted Therapy; Oleic Acid; Plasma; Rats; Rats, Sprague-Dawley; Stearoyl-CoA Desaturase; Tetrazoles | 2011 |
Comparison of intravascular ultrasound and quantitative coronary angiography for the assessment of coronary artery disease progression.
Topics: Acetamides; Acetates; Aged; Atherosclerosis; Biomarkers; Cineangiography; Coronary Angiography; Coronary Artery Disease; Disease Progression; Drug Therapy, Combination; Dyslipidemias; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Image Processing, Computer-Assisted; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Randomized Controlled Trials as Topic; Sterol O-Acyltransferase; Sulfonamides; Sulfonic Acids; Ultrasonography, Interventional | 2007 |